Enrollment is now complete for the largest randomized trial in cardiac surgery—6,500 patients strong!
The LeAAPS Trial will follow these patients over the next 5 years to evaluate whether AtriClip® devices for left atrial appendage exclusion (LAAE) can reduce stroke risk in high-risk patients without a history of Afib.
This simple addition to cardiac procedures could have a major impact.
Learn more about the trial here: <a href="https://okt.to/DBiQcy" target="_blank">https://okt.to/DBiQcy</a>
<a href='https://www.linkedin.com/feed/hashtag/?keywords=ClinicalTrial&highlight…; target='_blank'>#ClinicalTrial</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Stroke&highlightedUpdat…; target='_blank'>#Stroke</a>
